It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HLN’s FA Score shows that 1 FA rating(s) are green whileTAK’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HLN’s TA Score shows that 4 TA indicator(s) are bullish while TAK’s TA Score has 3 bullish TA indicator(s).
HLN (@Pharmaceuticals: Generic) experienced а -1.67% price change this week, while TAK (@Pharmaceuticals: Generic) price change was -1.23% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.29%. For the same industry, the average monthly price growth was +5.68%, and the average quarterly price growth was +62.35%.
HLN is expected to report earnings on Oct 30, 2025.
TAK is expected to report earnings on Oct 30, 2025.
A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
HLN | TAK | HLN / TAK | |
Capitalization | 39.1B | 46B | 85% |
EBITDA | 2.71B | 1.13T | 0% |
Gain YTD | -5.922 | 9.215 | -64% |
P/E Ratio | 19.66 | 50.60 | 39% |
Revenue | 11B | 4.48T | 0% |
Total Cash | 676M | 419B | 0% |
Total Debt | 8.45B | 4.51T | 0% |
TAK | ||
---|---|---|
OUTLOOK RATING 1..100 | 57 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 90 | |
PRICE GROWTH RATING 1..100 | 61 | |
P/E GROWTH RATING 1..100 | 37 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HLN | TAK | |
---|---|---|
RSI ODDS (%) | 1 day ago44% | N/A |
Stochastic ODDS (%) | 1 day ago48% | 1 day ago37% |
Momentum ODDS (%) | 1 day ago39% | 1 day ago53% |
MACD ODDS (%) | 1 day ago38% | 1 day ago50% |
TrendWeek ODDS (%) | 1 day ago50% | 1 day ago48% |
TrendMonth ODDS (%) | 1 day ago41% | 1 day ago41% |
Advances ODDS (%) | 8 days ago55% | 8 days ago43% |
Declines ODDS (%) | 14 days ago52% | 1 day ago44% |
BollingerBands ODDS (%) | 1 day ago48% | 1 day ago51% |
Aroon ODDS (%) | 1 day ago45% | 1 day ago41% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SYSB | 89.82 | 0.14 | +0.15% |
iShares Systematic Bond ETF | |||
VCV | 10.60 | N/A | N/A |
INVESCO CALIFORNIA VALUE MUNI Income TRUST | |||
SSPY | 87.11 | N/A | N/A |
Stratified LargeCap Index ETF | |||
NVBT | 36.20 | -0.06 | -0.15% |
AllianzIM U.S. Large Cp Buffer10 Nov ETF | |||
GRID | 151.59 | -1.88 | -1.22% |
First Trust NASDAQ® Cln Edge®StGidIfsETF |
A.I.dvisor indicates that over the last year, HLN has been loosely correlated with HLNCF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLN jumps, then HLNCF could also see price increases.
Ticker / NAME | Correlation To HLN | 1D Price Change % | ||
---|---|---|---|---|
HLN | 100% | +0.34% | ||
HLNCF - HLN | 49% Loosely correlated | +1.26% | ||
TAK - HLN | 42% Loosely correlated | -0.62% | ||
ZTS - HLN | 39% Loosely correlated | -1.78% | ||
PRGO - HLN | 32% Poorly correlated | -1.68% | ||
VTRS - HLN | 29% Poorly correlated | +0.10% | ||
More |
A.I.dvisor indicates that over the last year, TAK has been loosely correlated with HLN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then HLN could also see price increases.
Ticker / NAME | Correlation To TAK | 1D Price Change % | ||
---|---|---|---|---|
TAK | 100% | -0.62% | ||
HLN - TAK | 42% Loosely correlated | +0.34% | ||
SGIOY - TAK | 41% Loosely correlated | -1.27% | ||
ESAIY - TAK | 35% Loosely correlated | -1.96% | ||
BNXTF - TAK | 32% Poorly correlated | +2.58% | ||
ZTS - TAK | 30% Poorly correlated | -1.78% | ||
More |